pillbase.ru

Xtandi

Active substance: enzalutamide

enzalutamide

Centralised EU authorisationActive

Marketing holder: Astellas Pharma Europe B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 5
  • Xtandi
    TABLET · ENZALUTAMIDE 80 mg/1
    0469-0725
    Astellas Pharma US, Inc.
  • Xtandi
    TABLET · ENZALUTAMIDE 40 mg/1
    0469-1725
    Astellas Pharma US, Inc.
  • Xtandi
    CAPSULE · ENZALUTAMIDE 40 mg/1
    0469-0125
    Astellas Pharma US, Inc.
  • Xtandi
    TABLET · ENZALUTAMIDE 40 mg/1
    0469-0625
    Astellas Pharma US, Inc.
  • Xtandi
    CAPSULE · ENZALUTAMIDE 40 mg/1
    0469-1125
    Astellas Pharma US, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-2762-7219-90ef-c8fdee461e50,01a1208c-2767-7813-8840-a53bbbcf894f,01a1208d-b65b-7764-a1e5-a4c6aa9a9bfe,01a1209b-f3ae-74c2-83ac-5b4837cea056,01a1209e-596a-7123-babe-fe24bd193cf7;count=5 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002639
Registration status
Active
ATC code
L02BB04
Sources
  • product · EMA · EMEA/H/C/002639 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002639 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002639 · Verified 2026-10-09